Navigation Links
Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt
Date:2/9/2010

NEW YORK and TOKYO, Feb. 9 /PRNewswire/ -- Sony Corporation (Sony) announced today that it has acquired iCyt Mission Technology, Inc. (iCyt), a leading producer of high-performance cell sorters used for stem cell and disease research, through its U.S. subsidiary, Sony Corporation of America (SCA).  With this acquisition, Sony is applying its expertise and technologies to enter the flow cytometry business in the life science field.  iCyt, founded in 1995 and headquartered in Champaign, Illinois, designs, manufactures and sells flow cytometers, associated reagents and services.

"Sony brings an amazing level of technology and engineering capability to the field of cytometry," said Gary Durack, founder, President & CEO of iCyt.  "As a Sony company, iCyt will be able to leverage Sony's global resources to deliver a variety of innovative solutions to the cell analysis market.  This is truly a win for iCyt, its customers, and all who will benefit from these advances."  

"We are very pleased to welcome Gary Durack, who has extensive experience in the flow cytometry industry, and iCyt to the Sony family," said Keiji Kimura, EVP of Sony.  "iCyt's experience and technologies will be valuable assets for Sony as it enters into the rapidly evolving life science field.  We are confident that this acquisition will accelerate the development of Sony's flow cytometry business by combining Sony's expertise in the manufacturing of electronics products for consumers and professionals with the technological assets of iCyt."

As a wholly-owned subsidiary of SCA, iCyt plans to develop advanced technologies and deliver new products in collaboration with Sony.  Gary Durack will continue to lead the company through this period of growth and expansion.

New products and advancements will be announced at CYTO 2010 (www.cytoconference.org), the upcoming Congress of the International Society for Advancement of Cytometry (ISAC), in Seattle in May 2010.

Sony has been exploring healthcare applications for its consumer-based optic technologies, such as those used for Blu-ray discs and its advanced data processing technologies.  Recent progress in regenerative medicine has highlighted the importance of cell analysis and, specifically, flow cytometry, an indispensable tool for research.  Sony plans to realize unique technological advances in flow cytometry through the application of its core technologies.  As part of this effort, Sony and iCyt have been jointly developing new flow cytometry devices since April 2009.  Through this acquisition, Sony expects to accelerate its development of next-generation cell analysis systems and deliver innovative products to research and clinical laboratories around the world.

About Sony Corporation:

Sony Corporation is a leading manufacturer of audio, video, game, communications, key device and information technology products for the consumer and professional markets.  With its music, pictures, computer entertainment and on-line businesses, Sony is uniquely positioned to be the leading electronics and entertainment company in the world.  Sony recorded consolidated annual sales of approximately $79 billion for the fiscal year ended March 31, 2009.  Sony Global Web Site: http://www.sony.net/

About iCyt:

iCyt supplies advanced flow cytometry analysis and sorting technology for use in life science research.  Its products are marketed to private and public research institutions, pharmaceutical and biotechnology companies, and large medical centers.  iCyt has received significant industry recognition for its line of multi-channel, high-speed cell sorting products.  iCyt Web Site: http://www.i-cyt.com/

SOURCE Sony Corporation of America

RELATED LINKS
http://www.sony.com

'/>"/>

SOURCE Sony Corporation of America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
2. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
5. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
6. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
7. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
8. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
9. Juvaris BioTherapeutics Announces Cooperative Research and Development Agreement With The Centers for Disease Control and Prevention
10. AcroMetrix Renews Contract With Group Services for Americas Blood Centers
11. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/10/2017)... 10, 2017  The Corporate Whistleblower Center says, ... sleep therapy clinics to call us anytime at ... is involved in a substantial scheme to overbill ... from an employee of a medical equipment company ... to provide medical practice groups with extra generous incentives ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... that the Canadian Intellectual Property Office has granted ... Oral Administration of Exenatide". The patent covers Oramed,s ... GLP-1 is an incretin hormone that ...
(Date:5/6/2017)... , May 5, 2017  May is Stroke ... one of the most important methods to prevent a ... the Centers for Disease Control and Prevention, undetected and ... 1 Omron, the global leader in personal heart ... the elimination of heart attack and stroke and is ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 26, 2017 , ... Amir Qureshi, MD is the first physician in Arkansas ... stimulation system. The Nuvectra™ Algovita SCS System has been FDA approved as a treatment ... in Arkansas to introduce the most powerful SCS system and the only stretchable lead ...
(Date:5/26/2017)... ... May 26, 2017 , ... On May 24, the ... narrowly passed the U.S. House on May 4, would result in 23 million Americans ... continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). , ...
(Date:5/26/2017)... ... May 26, 2017 , ... Dr. Alex Rabinovich, a ... announce a new, informational blog post on insurance options. If a Bay Area patient ... may help save time and money. Visiting an in-network provider for a second opinion ...
(Date:5/26/2017)... , ... May 26, 2017 , ... “Cactus Jack: Against ... on so many others. “Cactus Jack: Against All Odds” is the creation of ... Walter D. Hubbard is married to Jack Carlisle’s third child Jane. Walter. Walter ...
(Date:5/24/2017)... Hills, CA (PRWEB) , ... May 24, 2017 , ... ... announced today its participation in nVerge 2017 – a one-day technology conference in San ... Altec’s document management solution, which allows users to fully utilize and enhance their Sage ...
Breaking Medicine News(10 mins):